SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Metcalf who wrote (852)6/24/1997 8:42:00 PM
From: scaram(o)uche   of 6136
 
for disclosure.....

I haven't posted much in this thread over the last few months. However, I was an early proponent for AGPH here at SI and in misc.invest.stocks since Spring '95. So......

for the sake of disclosure...... I sold my AGPH shares a couple of weeks ago. I like to find early-stage companies that I think are undervalued, companies with good bench scientists and flexible business plans. I don't feel comfortable with companies as they transition to profit. It's just my style.

Peter Johnson, Donna Nichols et al. have, IMO, consistently set realistic objectives and communicated honestly and openly about their chances. I have merely moved my AGPH profits to companies that are at an earlier stage of development, companies that are more of a "venture" model. Thus far, I've left about $4/share on the table. :-(

I still say that Japan Tobacco would be nuts not to consider a big hunk of Agouron.

I'm outta here. Good luck to everyone in all your investments!

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext